LVO usually does not require treatment or cause serious symptoms. However, treatment may be an option for those concerned with the appearance of the LVO in the language, or who have disseminated lesions and experience discomfort or taste changes due to the plates.

The usual method for treating viral LVO is taken orally (by mouth). Usually, these medicines are taken for one to two weeks or until the plates of the LVO disappear.
Other options include tretinoin (Retin A) and podophyllin resin, two drugs that can be applied directly to the plates of LVO. Usually tretinoin is applied two or three times a day until the plates are gone. Podophyllin it operates a health care provider once or twice during a period of two to three weeks. Other options, especially if the plates are small, is that a healthcare provider applies liquid nitrogen (cryotherapy) to the affected area, or surgery to remove the plates.

Can you prevent the LVO?

There is no sure way to prevent the plates of the LVO. However, the best way to prevent it can be to maintain healthy immune system. This means keeping viral load low and high T cells, using anti-HIV treatment, and adopting a healthy lifestyle.

Is there any treatment for developing LVO?

Currently, there are drugs in development to treat LVO as an opportunistic infection is not serious, and that there are medications to treat it. If you are interested in participating in any clinical trials with new therapies for the treatment or prevention of LVO, there is an interactive site aimed for finding clinical trials is AIDSinfo.nih.gov a site run by the National Institutes of Health United States (National Institutes of Health). These pages are “specialists in health information, with whom you can communicate by calling toll free 1-800-HIV-0440 (1-800-448-0440).

Oral hairy leukoplakia (LVO) is one or more white patches that can appear in the mouth. Normally, these plaques appear along the border of the tongue, but sometimes develop on the top or bottom of the tongue or along the inside of the cheek. If you look closely, these plaques can appear hairy or contain a number of small folds or bumps.

The LVO may look like thrush (oral candidiasis), another common problem characterized by white patches that develops in the mouths of people with HIV. However, if canker scraped gently using a toothbrush, usually are removed, the LVO not.

The LVO is one of the first opportunistic infections that occur in people with HIV. May occur with any T-cell count While there are people with HIV with more than 500 T cells that developed LVO, is more common in those with T-cell counts under 200. It is noteworthy that the LVO may affect those with healthy immune systems, even those who are not infected with HIV.

It is considered a benign disease, since it rarely causes serious physical problems and cause no serious complications.

The Epstein-Barr virus (EBV) is causing the LVO. Most people worldwide are infected with EBV. But only some, including those with a weakened immune system, develop the disease.

Over 25% of HIV positive people LVO develops sometime during the course of infection. It is more common among HIV positive men and smokers.

What are the symptoms of LVO?

The classic symptom of the LVO are looking fluffy white patches (hairy) and bumps that develop on the edge of the tongue. Plates may also appear at the top or bottom of the tongue, or along the inside of the cheek. It is also possible that these plates do not exhibit villi and contain no visible bumps or creases.

In general, LVO causes no other symptoms. Therefore, many people may not know they have LVO unless you consider the tongue or inside the mouth to find the plates, which usually do not cause discomfort or affect the taste of food or liquids. In some cases, LVO may cause mild pain, taste changes and sharpen sensitivity to food temperatures.

How is it diagnosed the LVO?

Often, health professionals can diagnose by simply looking LVO white plates. To find out if LVO plates or thrush (candidiasis) may be a simple test of scaling. With the help of a trowel or brush teeth gently scraping the plate. If the board is clear with white scaling, it is probably thrush, not LVO.

To be sure if the white patch is LVO, your health care provider can send a sample to a lab for analysis. The lab will look for the Epstein-Barr virus (EBV) to confirm the diagnosis of LVO.

Incoming search terms for the article:

Diagnosis

The white color of the leukoplakia is caused by a thickening of the layers of prickle cell keratinocytes or taking a white color when wet. Histologically, the majority of benign biopsies show hyperkeratosis, acanthosis and chronic inflammation. Approximately 20% of cases show a dysp

lasia that can range from mild to moderate. The tendency of lesions to become malignant can be investigated by various methods, including the determination of mitotic index, apoptotic and Ki67 and the expression of proto-oncogenes p53 and Bax and Bcl2

From a clinical standpoint, the diagnosis of leukoplakia is done by excluding other diseases that produce similar lesions.

Candidiasis: the first step in establishing the differential diagnosis of a white lesion in oral mucosa is whether it can break off (as in pseudomembranous candidiasis) or not.

Lichen: if the lesion is located in the mucous membranes of both cheeks differential diagnosis must be established with lichen planus and lupus erythematosus. The final diagnosis was determined by biopsy and immunofluorescence

Injury: the most common are mucosal chewed and focal keratosis.

Inherited as white lesions white sponge nevus: family history and histologogía can distinguish from leukoplakia

Treatment

Elimination of risk factors causing discontinuation of snuff up to 50% regression of leukoplakia in which snuff is the etiological factor.

Retinoic acid: retinoic acid, vitamin A and other synthetic retinoids are a treatment option, but only get remissions in 40-60% of cases. Tretinoin has been administered in doses of 1 mg / kg / day orally for 2 to 3 months or, alternatively, topically in solution or 0.05% cream. However, to discontinue treatment usually occurs a recurrence of injuries.

Photodynamic Therapy: Photodynamic therapy has been introduced recently in the treatment of cancers and oral leukoplakia. This treatment is based on observation of Sutro in 1933 in breast cancers that cancerous tissue illuminated with Wood’s lamp emitting a red light, whereas normal tissues did green. Although the biochemical basis of this phenomenon is only partially known, has shown that neoplastic or dysplastic tissues showed a reduction of fluorescence especially in the green region of the spectrum, while only the red light is affected. Photodynamic therapy is based on the administration of a photosensitizing agent that causes selective irradiation is to tissues where it accumulates this. The light produces reactive oxygen species and other free radicals that destroy DNA, structural proteins and phospholipids.

Have published several studies on photodynamic therapy in the treatment of leukoplakia using sensitizing agent d-aminolevulinic acid (a precursor of heme) applied locally at the site of injury and an argon laser at 635 nm. In some studies, the percentage of referrals reached 80%. Although the number of clinical studies of photodynamic therapy is limited, the results suggest that this treatment may be superior to others, and is also well tolerated (only 30% of patients experience pain during treatment)

Ablative surgery: removal of oral leukoplakia can be accomplished by surgical excision. The carbon dioxide laser or Nd: YAG lasers have the advantage of speed, restricted hemorrhages, removal of the lesion at constant depth, low morbidity and reduced scar contraction. For the elimination of proliferative verrucous leukoplakia surgical excision is preferred because in this type of leukoplakia is higher recurrence when using the laser. Cryosurgery also has also been used, although it is used less and less due to a possible worsening of the dysplasia and the impossibility of obtaining samples for biopsies.

After eliminating patients should be monitored at intervals of 3 to 6 months. The recurrence ranges between 20-35% after surgical excision and between 9-22% after laser excision. Very often, the recurrent lesions were found in areas adjacent to the primary lesion. In all cases, only considered that healing has been complete if not observed any recurrence within 3 years after treatment. (bhakti)

Incoming search terms for the article:

Leukoplakia is defined as a stain or white plaque, which appears on the tongue or mucous membranes of the mouth, which can not be scraped or detached and can not be attributed clinically or pathologically by any other disease. The significance of this lesion is its relatively high incidence and it is considered a precancerous lesion at 5% of cases, progresses to squamous cell carcinoma.

From a clinical standpoint, leukoplakia is classified as:

* Homogeneous leukoplakia, the most frequent, with little risk of malignant transformation
* Nodular or mottled, very rare, with a relatively high risk of degeneration to cancer
* Erythroleukoplakia, similar to the homogeneous leukoplakia but surrounded by red lesions

Some authors include as verrucous leukoplakia fourth group, proliferative and aggressive very rare, with increased risk of malignant transformation and are often seen as an advanced stage of homogeneous leukoplakia.

Homogeneous leukoplakia is a lesion uniformly white, firm, not very thick and smooth or rough. Nodular leukoplakia is a raised lesion with inhomogeneous edges presented with small rounded white and red elevations of the mucosa that give a granular appearance. It is also called speckled leukoplakia. The erythroleukoplakia is characterized by being surrounded by erythematous areas, sometimes with erosions. Finally, the proliferative verrucous leukoplakia, first described in 1984 is an exophytic lesion, persistent, warty and clinically aggressive and resistant to treatment.

Etiopathology

Of leukoplakias can be classified as induced by external factors and idiopathic. The snuff is one of major causes of this disease, with snuff leukoplakias by between 6 and 10 times more frequent than those resulting from other causes.

Other factors that have been viewed as inducing factors of leukoplakia are excessive alcohol consumption, poor diet with vitamin or mineral deficiencies, bad habits of compulsive (nibble parts of the mouth), poor oral hygiene and ill-fitting dentures or the existence of sharp angles of the crowns and fillings. The Viodent (a mouthwash based on an active principle of Sanguinaria canadensis) has been implicated in the development of oral leukoplakia.
Many authors consider some infectious diseases (infections with Candida, syphilis, infections with human papillomavirus (HPV) as etiological factors of leukoplakia (bhakti)

Morphine is a drug that is routinely provided to cancer patients to relieve pain. Recent studies conducted in the laboratory suggest that morphine may stimulate the spread of the disease. The researchers said this opioid promotes the growth of new blood vessels that carry oxygen and nutrients to tumors.

The scientists, who presented their findings during the joint conference of the American Association of Cancer Research and the European Organization for Research and Treatment of Cancer, held in Boston, also reported the discovery of a new drug that could counteract this effect. Experts say, however, that more testing is needed before carrying out any change in treatment.

The two new studies by the University of Chicago found that lung cancer by protecting cells from the effect of opioids will reduce the proliferation and cell migration. Dr. Patrick Singleton, head of the studies reported that in laboratory tests morphine not only strengthened but blood vessels appeared to facilitate the invasion and spread of cancer cells to other tissues. However, it appears that this can be overcome with another drug, called naltrexone, or methyl-MNTX.

Morphine, a potent opioid analgesic, has been for over two centuries, the standard treatment to combat chronic pain of cancer patients. Since research is in its early stages is not yet say whether opioid-based painkillers have an effect on cancer growth. Therefore, we must continue with studies.

Use the best fat burner pills to burn your weight!

Incoming search terms for the article:

If we talk about natural medicines tea must occupy one of the top positions in regard to properties. In this case specifically discuss the benefits of white tea. Is that according to the latest research should take this into account when choosing what type of tea drinking. At least in case you want to reduce the risk of cancer, rheumatoid arthritis and even wrinkles associated with age.

A study by the University of Kingston He tested the health properties of 21 plants and herbal extracts. They found that all these plants had some kind of benefit. However, white tea seems to stand above them. According to these studies, white tea has important anti-aging properties and a high level of antioxidants. As we know, antioxidants we prevent cancer and heart disease.

According to the results of research on white tea prevents the activity of enzymes that degrade elastin and collagen. Therefore, time can be beneficial to prevent wrinkles that accompany aging. These enzymes, along with other oxidants, are associated with the onset of inflammatory diseases such as rheumatoid arthritis.

In conclusion, the indicators show that white tea reduces the risk of inflammation characteristic of rheumatoid arthritis and some cancers, as well as wrinkles. Eight of the tested plants and herbs also seem to protect against loss of elastin and collagen. White tea is followed by extracts benefits of blade, pink, green tea, angelica and anise, among others.

Incoming search terms for the article:

The use of deodorant could affect the growth of breast cancer in women: no scientific studies have demonstrated this possibility. A group of experts from the French Cancer Society made a detailed and scientific analysis on this subject. Conclusion: No scientific evidence has been identified for this hypothesis.

Breast Cancer: deodorants Charged

Several studies have noted a high incidence of breast cancer at the area close to the application of anti-perspirant deodorant (the upper outer quadrant) and use more and more frequent these products.

Based on these findings, several research teams have sought to establish a possible link between antiperspirants and breast cancer. The assumption most played retained the possible role of parabens and aluminum salts. However, to date, no prospective epidemiological study has demonstrated the hypothesis that the use of deodorants had an impact on the growth of breast cancer in women.

No scientific evidence

A group of experts whose findings were published in the journal Cancer Bulletin, Official Organ of the French Cancer Society, gave a detailed scientific analysis to address the anxiety of women on this subject. They were well reviewed 59 studies from the literature and 19 items of different methodology. Their conclusion? No scientific evidence for the hypothesis could not be identified. Moreover, these experts explain that there remains no validated hypothesis may open up channels of interesting research. They argue that this issue does not constitute a public health problem and it seems pointless to continue research on this topic.

The French Agency for Sanitary Safety of Health Products (AFSSAPS) was published in 2006 from information in the same direction. Thus, no reason for concern about the use of any deodorant.

The importance of screening for breast cancer

The known risk factors for breast cancer? A minority of breast cancers is related to a family who inherited form occurs most often at a young age, one of the major risk factors remaining estrogen. Thus prevention of this scourge women based primarily on the screening mammography.

Breast cancer remains the most common cancer of women in Western countries: it affects one in nine women, mostly after menopause. It caused 11 000 deaths in France in 2005. More breast cancer is detected early, the greater the chances of recovery are important. With early detection, half of breast cancers are detected when they are less than 2 cm. This level of detection can reach very high cure rates while substantially reducing the aggressiveness of treatment applied. At any age, you must be regularly monitored by a doctor or a gynecologist who will prescribe the necessary examinations, particularly if it considers that you have family risk factors for breast cancer. This medical must be conducted every 6 months or every year from 30 years.

In France, the organized screening (every two years, a mammogram supported 100% by the Health Insurance without advance fee) is available to women from 50 years to 74 years. Against breast cancer, go for screening!